Frontlight ResearchEarly access
Trial site
The University of Chicago Medicine
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Liver cirrhosis3 trials
- Diffuse large B-cell lymphoma2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- High blood pressure2 trials
- Melanoma2 trials
- Ovarian cancer2 trials
- Amyloidosis1 trial
- Bladder cancer1 trial
- Burkitt lymphoma1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Follicular lymphoma1 trial
- and 6 more
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 13 trials
- Phase 1/22 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting4 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Incyte Corporation2 trials
- Madrigal Pharmaceuticals, Inc.2 trials
- Mineralys Therapeutics Inc.2 trials
- ModernaTX, Inc.2 trials
- argenx1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver cirrhosis2 recruiting
- Amyloidosis1 recruiting
- Childhood cancers1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Terminated
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
Completed
Completed
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Completed
Completed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Site data: ClinicalTrials.govUpdated 18 Nov 2026